Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Braz. j. med. biol. res ; 50(12): e5916, 2017. tab, graf
Article in English | LILACS | ID: biblio-888970

ABSTRACT

Lider-7-tang, a medicine used for the treatment of respiratory diseases especially pneumonia and fever in Mongolian Traditional Medicine, was selected for this phytochemical and pharmacological study. The objectives of the study were to determine total biological active substances and analyze the effects of Lider-7-tang treatment in rats with acute lung injury (ALI). Quantitative determination of the total active constituents (phenolic, flavonoid, iridoid and alkaloid) of the methanol extract of Lider-7-tang was performed using Folin-Ciocalteu reagent, aluminum chloride reagent, Trim-Hill reagent, and Bromocresol green reagent, respectively. A total of fifty 8-10-week-old male Wistar rats (200-240 g) were randomized into three groups: control group, lipopolysaccharide (LPS) group (7.5 mg/kg) and LPS+Lider-7 group (90 mg/kg Lider-7-tang before LPS administration). The total content of alkaloids was 0.2±0.043%, total phenols 7.8±0.67%, flavonoids 3.12±0.206%, and iridoids 0.308±0.0095%. This study also evaluated the effects of Lider-7 on levels of inflammatory mediators by observing histopathological features associated with LPS-induced ALI. The rats pretreated with Lider-7 had significantly lower levels of IL-6 (at 3 and 6 h), and TNF-α (at 3, 6, 9, and 12 h). The current study showed that Lider-7 exerted a preventive effect against LPS-induced ALI, which appeared to be mediated by inhibiting the release of pro-inflammatory cytokines.


Subject(s)
Animals , Male , Acute Lung Injury/prevention & control , Alkaloids/pharmacology , Flavonoids/pharmacology , Iridoids/pharmacology , Phenols/pharmacology , Plants, Medicinal/chemistry , Acute Lung Injury/pathology , Alkaloids/analysis , Enzyme-Linked Immunosorbent Assay , Flavonoids/analysis , Indicators and Reagents , Interleukin-6/blood , Iridoids/analysis , Lipopolysaccharides , Lung/drug effects , Lung/pathology , Molybdenum , Mongolia , Phenols/analysis , Phytotherapy/methods , Protective Agents/pharmacology , Rats, Wistar , Reproducibility of Results , Spectrophotometry , Time Factors , Treatment Outcome , Tumor Necrosis Factor-alpha/blood , Tungsten Compounds
2.
IJPR-Iranian Journal of Pharmaceutical Research. 2012; 11 (4): 1255-1263
in English | IMEMR | ID: emr-155480

ABSTRACT

In this study, it was surveyed to know whether an oral single dose of oleuropein could mimic the cardiac preconditioning in rats' hearts or whether its prolonged oral administration could protect the heart against the aconitine-induced arrhythmia in rats. Eighty male Wistar rats were divided into two series [n = 8 in each group]. In the first series, all groups [except the control [Con] group] were given a single oral dose of oleuropein [20 mg/Kg] 1, 3, 24 and 48 h before the infusion of aconitine. In the second series, except the Con group, the other four groups were given oral oleuropein [20 mg/Kg/day] for 3, 7, 14 and 28 days, before the infusion of aconitine. Electrocardiogram was recorded to monitor arrhythmia. Data of the first series showed that the initiation time of arrhythmia, the initiation of ventricular tachycardia [VT], the numbers of reversible ventricular fibrillation [VF] and the death time had no significant difference compared with Con group. In the second series, a significant protection was occurred only in the 28 days group that was evident with increased initiation time of arrhythmia, increased initiation time of VT, and increased the number of reversible VF and death time in compared to the Con group. The findings of this study show that the oral administration of a single dose of oleuropein could not mimic the preconditioning effects in rat hearts, but the prolonged administration of oleuropein for about four weeks could protect the heart against aconitine-induced arrhythmia


Subject(s)
Animals, Laboratory , Iridoids/pharmacology , Rats , Aconitine/adverse effects , Arrhythmias, Cardiac/therapy , Administration, Oral , Rats, Wistar
3.
Article in English | IMSEAR | ID: sea-136329

ABSTRACT

Background & objectives: The severe toxicity, exorbitant cost and emerging resistance of Leishmania species against most of the currently used drugs underscores the urgent need for the alternative drugs. The present study evaluates in vitro anti-leishmanial activity of Plumeria bicolor and its isolated compounds. Methods: The in vitro anti-parasitic activity of chloroform extract of Plumeria bicolor, plumericin and isoplumericin were tested alongwith appropriate controls against promastigote and amastigote forms of Leishmania donovani using 96 well microtiter plate. The concentration used for assessing the anti-leishmanial activity of extract of Plumeria bicolor and both isolated compounds were 100 μg/ml and 15 μM, respectively. The viability of the cells was assessed by MTT assay. The cytotoxicity of these compounds was performed against J774G8 murine macrophage cells lines at the concentration of 30 μM. Results: The Plumeria bicolor extract showed activity with the IC50 of 21±2.2 and 14±1.6 μg/ml against promastigote and amastigote forms of L. donovani, respectively. Plumericin consistently showed high activity with the IC50 of 3.17±0.12 and 1.41±0.03 μM whereas isoplumericin showed the IC50 of 7.2±0.08 μM and 4.1±0.02 μM against promastigote and amastigote forms, respectively. Cytotoxic effect of the chloroform extract of P. bicolor, plumericin and isoplumericin was evaluated in murine macrophage (J774G8) model with CC50 value of 75±5.3 μg/ml, 20.6±0.5 and 24±0.7 μM, respectively. Interpretation & conclusions: Our results indicated that plumericin showed more potent activity than isoplumericin and might be a promising anti-leishmanial agent against L. donovani.


Subject(s)
Animals , Antiparasitic Agents/pharmacology , Apocynaceae/chemistry , Cell Line , Humans , Indenes/pharmacology , Inhibitory Concentration 50 , Iridoids/pharmacology , Leishmania/drug effects , Leishmania/parasitology , Leishmania donovani/drug effects , Leishmania donovani/pathogenicity , Macrophages/cytology , Mice , Plant Extracts/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL